Literature DB >> 25535212

Survey of dietary and medication practices of owners of cats with chronic kidney disease.

Jessica E Markovich1, Lisa M Freeman1, Mary A Labato1, Cailin R Heinze1.   

Abstract

The objective of this study was to describe the dietary and medication patterns of cats with chronic kidney disease (CKD). In this prospective, cross-sectional descriptive study, owners of cats with CKD were asked to complete a web-based survey. The study was advertised on CKD-, pet-, veterinary- and breed-associated websites and list serves. Owners of 1089 cats with CKD participated in the study. The mean reported age of the cats with CKD was 13.7 ± 4.2 years. Forty percent (430/1089) of cats had concurrent diseases, with hyperthyroidism, heart disease and inflammatory bowel disease being the most common. Veterinarian recommendation was the most common reason reported (684/1032; 66%) for diet selection, and 51% (556/1089) of owners fed a veterinary therapeutic diet formulated for kidney disease as some component of the diet. Many owners (466/1079; 43%) reported that their cats had an abnormal appetite; of these owners, 52% responded that their cats had a poor appetite or required coaxing to eat 5-7 days per week. Forty-seven percent and 51% of cats were receiving subcutaneous fluids and oral medications, respectively; however, most cats (811/1036; 78%) were not receiving phosphorus-binding medications. Fifty-six percent and 38% of cats received commercial cat treats and dietary supplements, respectively. Anorexia or hyporexia is a common problem in cats with CKD and may lead to cats being fed suboptimal diets for their disease. This information may be useful for treating or designing nutritional studies for cats with CKD. © ISFM and AAFP 2014.

Entities:  

Mesh:

Year:  2014        PMID: 25535212     DOI: 10.1177/1098612X14563097

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  10 in total

1.  Veterinarians' attitudes towards use of nutraceuticals.

Authors:  Susan M Elrod; Erik H Hofmeister
Journal:  Can J Vet Res       Date:  2019-10       Impact factor: 1.310

2.  A long term feed supplementation based on phosphate binders in Feline Chronic Kidney Disease.

Authors:  E Biasibetti; E Martello; M Bigliati; I Biasato; T Cocca; N Bruni; M T Capucchio
Journal:  Vet Res Commun       Date:  2018-03-26       Impact factor: 2.459

3.  Evaluation of Weight Loss Over Time in Cats with Chronic Kidney Disease.

Authors:  L M Freeman; M-P Lachaud; S Matthews; L Rhodes; B Zollers
Journal:  J Vet Intern Med       Date:  2016-08-16       Impact factor: 3.333

4.  Evaluation of Gastric pH and Serum Gastrin Concentrations in Cats with Chronic Kidney Disease.

Authors:  M K Tolbert; S Olin; S MacLane; E Gould; J M Steiner; S Vaden; J Price
Journal:  J Vet Intern Med       Date:  2017-08-20       Impact factor: 3.333

5.  The frequency of oral famotidine administration influences its effect on gastric pH in cats over time.

Authors:  Elizabeth Golly; Adesola Odunayo; Maggie Daves; Julie Vose; Josh Price; Silke Hecht; Joerg M Steiner; Shanna Hillsman; M Katherine Tolbert
Journal:  J Vet Intern Med       Date:  2019-02-12       Impact factor: 3.333

6.  Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease.

Authors:  Jessica M Quimby; Kellyi K Benson; Stacie C Summers; Ashlie Saffire; Andrea K Herndon; Shasha Bai; Daniel L Gustafson
Journal:  J Feline Med Surg       Date:  2019-06-04       Impact factor: 2.015

7.  Evaluation of nutrient content and caloric density in commercially available foods formulated for senior cats.

Authors:  Stacie C Summers; Jonathan Stockman; Jennifer A Larsen; Anais Sanchez Rodriguez; Lei Zhang
Journal:  J Vet Intern Med       Date:  2020-07-10       Impact factor: 3.333

8.  Appetite-stimulating effects of once-daily omeprazole in cats with chronic kidney disease: Double-blind, placebo-controlled, randomized, crossover trial.

Authors:  Ashley Spencer; Jessica M Quimby; Josh M Price; Sally MacLane; Shanna Hillsman; Patty Secoura; Jörg M Steiner; M Katherine Tolbert
Journal:  J Vet Intern Med       Date:  2021-09-30       Impact factor: 3.333

9.  ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats.

Authors:  Stanley L Marks; Peter H Kook; Mark G Papich; M K Tolbert; Michael D Willard
Journal:  J Vet Intern Med       Date:  2018-10-31       Impact factor: 3.333

10.  Evaluation of phosphorus, calcium, and magnesium content in commercially available foods formulated for healthy cats.

Authors:  Stacie C Summers; Jonathan Stockman; Jennifer A Larsen; Lei Zhang; Anais Sanchez Rodriguez
Journal:  J Vet Intern Med       Date:  2019-12-28       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.